| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |